Detailed Information on Publication Record
2018
Gene target selection for loop-mediated isothermal amplification for rapid discrimination of Treponema pallidum subspecies
KNAUF, Sascha, Simone LUERT, David ŠMAJS, Michal STROUHAL, Idrissa S. CHUMA et. al.Basic information
Original name
Gene target selection for loop-mediated isothermal amplification for rapid discrimination of Treponema pallidum subspecies
Authors
KNAUF, Sascha (276 Germany, guarantor), Simone LUERT (276 Germany), David ŠMAJS (203 Czech Republic, belonging to the institution), Michal STROUHAL (203 Czech Republic, belonging to the institution), Idrissa S. CHUMA (276 Germany), Sieghard FRISCHMANN (276 Germany) and Mohammed BAKHEIT (276 Germany)
Edition
PLoS neglected tropical diseases, San Francisco, Public Library of Science, 2018, 1935-2735
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30309 Tropical medicine
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 4.487
RIV identification code
RIV/00216224:14110/18:00104105
Organization unit
Faculty of Medicine
UT WoS
000433487700036
Keywords in English
gene target
Tags
International impact, Reviewed
Změněno: 10/2/2019 13:08, Soňa Böhmová
Abstract
V originále
We show proof of concept for gene targets (polA, tprL, and TP_0619) that can be used in loop-mediated isothermal amplification (LAMP) assays to rapidly differentiate infection with any of the three Treponema pallidum subspecies (pallidum (TPA), pertenue (TPE), and endemicum (TEN)) and which are known to infect humans and nonhuman primates (NHPs). Four TPA, six human, and two NHP TPE strains, as well as two human TEN strains were used to establish and validate the LAMP assays. All three LAMP assays were highly specific for the target DNA. Amplification was rapid (5-15 min) and within a range of 10E+6 to 10E+2 of target DNA molecules. Performance in NHP clinical samples was similar to the one seen in human TPE strains. The newly designed LAMP assays provide proof of concept for a diagnostic tool that enhances yaws clinical diagnosis. It is highly specific for the target DNA and does not require expensive laboratory equipment. Test results can potentially be interpreted with the naked eye, which makes it suitable for the use in remote clinical settings.